lime 12 corp

1220 broadway suite 706
new york, new york 10001

NYS Entity Status
ACTIVE

NYS Filing Date
APRIL 22, 2013

NYS DOS ID#
4391670

County
NEW YORK

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC BUSINESS CORPORATION

Name History
2013 - LIME 12 CORP









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • LimeBike raises $50 million to expand dockless bike-sharing
    By Bérénice Magistretti - Monday Oct 16, 2017

    Just a few months after launching with a $12 million seed round, dockless bike-sharing startup LimeBike announced today that it has secured a whopping $50 million to expand nationwide. Coatue Management led the investment, with participation from new investors, including GGV Capital, Bill Maris’ Section 32, Franklin Templeton Investments, AME Cloud Ventures, and Stanford’s StartX […]

    Source: VentureBeat
  • Near The East River, Plans Emerge For NY’s Next Life Science Center
    By Ben Fidler - Monday Aug 21, 2017

    At a time when biotech incubators and shared spaces are beginning to multiply in Manhattan, work on what could rank among the city’s largest biotech centers—if it can all come together—is just getting underway. According to Paul Wexler, a longtime healthcare-focused real estate broker, construction should begin next year on what is being called the […]

    Source: Xconomy New York
  • Billionaires, Bruised Egos, and the Death of a Grand Project
    By CHARLES V. BAGLI and ROBIN POGREBIN - Sunday Sep 24, 2017

    Barry Diller was about to win the battle for his $250 million arts pier, but then came the “petty questions” from his opponents and he decided to pull the plug.

    Source: NYT > Home Page
  • Using Lime Sulfur In Gardens: When And How To Use Lime Sulfur
    By Darcy Larum - Sunday Jul 2, 2017

    Source: Gardening Know How
  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy New York